Synlogic Announces Data Presentations at the 2023 Synthetic Biology: Engineering, Evolution & Design (SEED) ConferenceGlobeNewsWire • 05/24/23
Synlogic Reports First Quarter 2023 Financial Results and Provides Business UpdateGlobeNewsWire • 05/11/23
Synlogic Receives Orphan Drug Designation from FDA for SYNB1934 for Treatment of PhenylketonuriaGlobeNewsWire • 05/09/23
Analysts Estimate Synlogic, Inc. (SYBX) to Report a Decline in Earnings: What to Look Out forZacks Investment Research • 05/04/23
Synlogic Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate UpdatesGlobeNewsWire • 03/29/23
Synlogic Receives Positive Opinion on Orphan Designation from the European Medicines Agency for SYNB1934 for the Treatment of PhenylketonuriaGlobeNewsWire • 03/28/23
Synlogic Announces Data Presentations at the Society for Inherited Metabolic Disorders (SIMD) 44th Annual MeetingGlobeNewsWire • 03/20/23
Synlogic To Present Three Data Presentations at the Society for Inherited Metabolic Disorders (SIMD) 44th Annual MeetingGlobeNewsWire • 03/07/23
Synlogic Announces Participation in Upcoming Investor and Industry ConferencesGlobeNewsWire • 01/24/23
Synlogic Receives Rare Pediatric Disease Designation from FDA for SYNB1934 for Phenylketonuria (PKU)GlobeNewsWire • 01/19/23
Synlogic Announces Appointment of Dr. Dave Hava as Head of Research and DevelopmentGlobeNewsWire • 01/03/23
Synlogic Announces Achievement of Proof of Concept for SYNB8802 in Enteric Hyperoxaluria Based on Urinary Oxalate Lowering in Phase 1b StudyGlobeNewsWire • 12/15/22
Synlogic Announces SYNB1353 Achieves Proof of Mechanism for Treatment of Homocystinuria and Provides Business UpdateGlobeNewsWire • 11/30/22
Synlogic Reports Third Quarter 2022 Financial Results and Provides Business UpdateGlobeNewsWire • 11/10/22
Synlogic Announces Positive Top-Line Phase 2 Data for Phenylketonuria (PKU); SYNB1934 Advances to Phase 3GlobeNewsWire • 10/18/22
Synlogic Achieves Research Milestone in Collaboration with Roche for Development of Novel Synthetic Biotic to Treat Inflammatory Bowel DiseaseGlobeNewsWire • 09/06/22